Antibody‐Directed Cancer Therapy Using Cubic‐Shaped Magnetic Nanoparticles for Combined Hyperthermia and Drug Release
c
MNP‐mPEG‐Dox‐Ab) nanobioengineered for an integrated therapeutic approach. The cubic‐shaped MNPs (
c
MNP) are functionalized with a biocompatible polymer, mPEG‐NH
2
, to immobilize anti‐HER2 antibody and the anticancer drug doxorubicin. The nanoformulation exhibits a controlled drug release in response to pH and temperature stimuli. Notably, under an alternating magnetic field (AMF), 64% drug release is observed at an acidic pH, which mimics the tumor microenvironment. Cytotoxicity studies on the HCC1954 breast cancer cells reveal that the nanoformulation without an anti‐HER2 antibody induces 25% cell death, which increases to 52% upon conjugation with the anti‐HER2 antibody, confirming the bioactive targeting effect. Apoptosis studies demonstrate a significant increase in the apoptotic cell population under hyperthermic conditions relative to the physiological temperature. This study underscores the potential of
c
MNP‐mPEG‐Dox‐Ab nanoformulation to enhance the precision and therapeutic efficacy of multimodal cancer therapy through bioactive targeting.
No keywords indexed for this article. Browse by subject →
Rebecca L. Siegel, Kimberly D. Miller, Nikita Sandeep Wagle et al.
Rolf D. Issels
Jihye Yoo, Changhee Park, Gawon Yi et al.
H. Namduri, S. Nasrazadani
Andreas Barth
A. P. Grosvenor, B. A. Kobe, M. C. Biesinger et al.
Showing 50 of 77 references
- Published
- Jan 01, 2026
- Vol/Issue
- 21(2)
- License
- View
You May Also Like
Antoine Daina, Vincent Zoete · 2016
2,056 citations
Sulin Zhang, Yanling Wu · 2014
143 citations
William J. Scott, Martin F. Hentemann · 2016
112 citations
Leonid L. Fershtat, Nina N. Makhova · 2017
107 citations